Hisham A. ImadJuthamas PhadungsombatEmi E. NakayamaSajikapon KludkleebWasin MatseeThitiya PonamKeita SuzukiPornsawan LeaungwutiwongWatcharapong PiyaphaneeWeerapong PhumratanaprapinTatsuo ShiodaFaculty of Tropical Medicine, Mahidol UniversityTanaka Kikinzoku Kogyo K.K.Research Institute for Microbial DiseasesHospital for Tropical Diseases, Bangkok2022-08-042022-08-042021-01-01Tropical Medicine and Infectious Disease. Vol.6, No.1 (2021)241463662-s2.0-85106881424https://repository.li.mahidol.ac.th/handle/20.500.14594/77354Chikungunya virus is an Alphavirus belonging to the family Togaviridae that is transmitted to humans by an infected Aedes mosquito. Patients develop fever, inflammatory arthritis, and rash during the acute stage of infection. Although the illness is self-limiting, atypical and severe cases are not uncommon, and 60% may develop chronic symptoms that persist for months or even for longer durations. Having a distinct periodical epidemiologic outbreak pattern, chikungunya virus reappeared in Thailand in December 2018. Here, we describe a cohort of acute chikungunya patients who had presented to the Bangkok Hospital for Tropical Diseases during October 2019. Infection was detected by a novel antigen kit and subsequently confirmed by real-time RT-PCR using serum collected at presentation to the Fever Clinic. Other possible acute febrile illnesses such as influenza, dengue, and malaria were excluded. We explored the sequence of clinical manifestations at presentation during the acute phase and associated the viral load with the clinical findings. Most of the patients were healthy individuals in their forties. Fever and arthralgia were the predominant clinical manifestations found in this patient cohort, with a small proportion of patients with systemic symptoms. Higher viral loads were associated with arthralgia, and arthralgia with the involvement of the large joints was more common in female patients.Mahidol UniversityImmunology and MicrobiologyMedicineArticleSCOPUS10.3390/tropicalmed6010012